Table 4 |
||
|
Clinical features of 50 cases of ALK-DLBCL reported in the literature |
||
|
N |
%/range |
|
|
|
||
|
Age, years (n = 47) |
38 |
9 – 72 |
|
|
||
|
Sex (n = 50) |
||
|
|
||
|
Male |
38 |
76 |
|
|
||
|
Female |
12 |
24 |
|
|
||
|
Site of involvement (n = 46) |
||
|
Exclusively nodal |
24 |
52 |
|
Cervical |
17 |
71 |
|
Other |
7 |
29 |
|
Extranodal |
22 |
48 |
|
Bone |
8 |
36 |
|
Liver and spleen |
4 |
18 |
|
Head and neck |
3 |
14 |
|
Gastrointestinal tract |
3 |
14 |
|
Other* |
8 |
36 |
|
|
||
|
Clinical stage (n = 47) |
||
|
I – II |
20 |
43 |
|
III – IV |
27 |
57 |
|
|
||
|
Therapy (n = 41) |
||
|
Chemotherapy |
34 |
83 |
|
Chemoradiotherapy |
6 |
15 |
|
Radiotherapy |
1 |
2 |
|
|
||
|
Relapsed cases |
18 |
44 |
|
|
||
|
Salvage HSCT |
8 |
20 |
|
|
||
|
Survival time, months (n = 36) |
24 |
3 – 156 |
|
|
||
|
HSCT – hematopoietic stem cell transplantation *Includes bone marrow, CNS, gonads and muscle |
||
|
Beltran et al. Journal of Hematology & Oncology 2009 2:11 doi:10.1186/1756-8722-2-11 |
||
